Epigenetic therapy to sensitize patients

Grant Details

Grantee Name: Dr. Stephen Baylin and Dr. Julie Brahmer

Organization:
 John Hopkins University
Country: USA

Project Name:
 Epigenetic therapy to sensitize patients with advanced NSCLC to chemotherapy and immunotherapy targeting reversal of immune tolerance
Funding Year:
 2015
Project period: 6 years

Epigenetic therapy to sensitize patients with advanced NSCLC to chemotherapy and immunotherapy targeting reversal of immune tolerance

The team had found in an earlier study that epigenetic therapy appears to sensitize patients to subsequent treatments including chemotherapy, and very excitingly, to immunotherapy, targeting reversal of immune tolerance. 

Combined Shape Created with Sketch.
icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.